Published in Vaccine Weekly, December 21st, 1998
Serogroup B Neisseria meningitidis is a leading cause of meningitis and fulminant septicemia all over the world, including the U.S. The bug enters the body via the respiratory system and manages to survive in the bloodstream where it multiplies, causing various forms of invasive disease.
The ability of this germ to survive potent antibacterial defenses has been traced to its capsule and to a bacterially expressed lipooligosaccharide (LOS) with terminal sialic-acid residues. Indeed, new N. meningitidis vaccines...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.